Dr. Kevin Kalinsky discusses the role of targeted therapy and clinical decision-making in managing estrogen-driven, ...

Dr. Alan Tan explores circulating tumor DNA, its role in clinical trials and its potential impact on patients with renal cell ...

Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

After my last fall, where I broke both my upper front teeth and had abrasions on my face, I had to go to the ER to be checked ...

Dr. Chandler Park sat down for an interview with CURE® to discuss the biggest takeaway from the 2025 ASCO GU Symposium in ...

When my spouse and I both faced cancer, maintaining a positive attitude, seeking support, listening empathetically and ...

Dr. Kandace P. McGuire discusses how targeted axillary staging differs from traditional methods of staging in patients ...

The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ ...

Our longtime editor-in-chief offers advice to his successor while discussing the news and education CURE magazine provides ...

RECKGIST score may predict recurrence in neurofibromatosis type 1 GISTs, potentially guiding treatment decisions, according ...

Life-threatening lung cancer has taught me many valuable lessons and made my new normal so fulfilling. My life has changed ...

The first patient has been enrolled in the phase 3 PROSTATE-IQ trial being conducted in men with prostate cancer recurrence ...